Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MedL10N is the life sciences business unit launched by CSOFT International to provide multilingual localization, translation, and regulatory language services for pharmaceutical, biotechnology, medical device, CRO, and healthcare customers. The business focuses on supporting global product development and commercialization workflows, including clinical trial localization, CTD/eCTD submissions, linguistic validation, medical document translation, and medical device localization. Publicly available materials indicate that MedL10N has evolved under the broader CSOFT Health Sciences brand, which remains active as a commercial services organization rather than a therapeutic drug developer. Its offerings are designed to help life sciences companies navigate multilingual regulatory, clinical, and commercialization requirements across global markets. The organization appears to operate as a services/platform business in healthcare communications rather than a biotech company with an internal drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MedL10N.